Creative Planning

Position in HROW — Harrow, Inc.

CIK 1540235 OVERLAND PARK, KS

Position in HROW

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$785,345

-$430,247 QoQ

Shares Held

22,273

-10.2% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0.9024379293314776.ToString("F0")% Shared 0.ToString("F0")% None 99.09756207066852.ToString("F0")%

Healthcare · as of Mar 31, 2026

Creative Planning holds $105,843,094 across 40 Drug Manufacturers - Specialty & Generic names. HROW ranks #19 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd	1,167,182	$16,165,470
2	UTHR	UNITED THERAPEUTICS Corp	22,075	$13,090,033
3	VTRS	Viatris Inc	770,971	$10,415,817
4	TAK	Takeda Pharmaceutical Co Ltd	542,996	$10,056,285
5	ZTS	Zoetis Inc.	77,690	$9,183,734
6	NBIX	Neurocrine Biosciences Inc	68,387	$9,009,303
7	HLN	Haleon plc	630,997	$6,316,279
8	LNTH	Lantheus Holdings, Inc.	80,292	$6,090,147

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$785,345	22,273	-10.2%	Shares	Sole	2026-05-12
2025-12-31	$1,215,592	24,808	-25.2%	Shares	Sole	2026-02-17
2025-09-30	$1,597,455	33,156	-12.0%	Shares	Defined	2025-11-14
2025-06-30	$1,151,143	37,693	+21.8%	Shares	Defined	2025-08-08
2025-03-31	$823,429	30,956	+161.4%	Shares	Sole	2025-05-15
2024-12-31	$397,265	11,841	-37.0%	Shares	Sole	2025-02-14
2024-09-30	$845,382	18,803	-36.2%	Shares	Sole	2024-10-11
2024-06-30	$615,962	29,486	+96.8%	Shares	Sole	2024-08-15
2024-03-31	$198,264	14,986	+44.1%	Shares	Sole	2024-05-13
2023-12-31	$116,491	10,401	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.